We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+19.58%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$521M
AUM Growth
+$123M
Cap. Flow
+$74M
Cap. Flow %
14.2%
Top 10 Hldgs %
42.06%
Holding
160
New
57
Increased
37
Reduced
27
Closed
29

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$11.3M
2
AMZN icon
Amazon
AMZN
+$11.3M
3
EVA
Enviva Inc.
EVA
+$10.5M
4
MED icon
Medifast
MED
+$10.1M
5
CTLP
Cantaloupe
CTLP
+$8.31M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$13.6M
2
CVS icon
CVS Health
CVS
+$12.8M
3
RUN icon
Sunrun
RUN
+$11M
4
ADBE icon
Adobe
ADBE
+$10.1M
5
NOW icon
ServiceNow
NOW
+$8.57M

Sector Composition

Rank Sector Weight
1 Technology 26.67%
2 Industrials 16.23%
3 Healthcare 15.24%
4 Consumer Discretionary 7.69%
5 Consumer Staples 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIRG icon
101
Airgain
AIRG
$71.9M
$321K 0.06%
+25,000
New +$293K
CNC icon
102
Centene
CNC
$31.6B
$319K 0.06%
+6,000
New +$364K
TWTR
103
DELISTED
Twitter, Inc.
TWTR
$296K 0.06%
9,000
-3,000
-25% -$95.1K
LITE icon
104
Lumentum
LITE
$50.7B
$283K 0.05%
5,000
-3,000
-38% -$144K
NVTR
105
DELISTED
Nuvectra Corporation Common Stock
NVTR
$276K 0.05%
25,095
– –
FOLD
106
DELISTED
Amicus Therapeutics
FOLD
$272K 0.05%
20,000
-195,000
-91% -$2.38M
DDD icon
107
3D Systems Corp
DDD
$412M
$269K 0.05%
+25,000
New +$297K
PTE
108
CALL
DELISTED
PolarityTE, Inc. Common Stock
PTE
$268K 0.05%
+1,000
New +$370K
BNFT
109
DELISTED
Benefitfocus, Inc.
BNFT
$248K 0.05%
+5,000
New +$256K
ALBO
110
DELISTED
Albireo Pharma Inc
ALBO
$245K 0.05%
7,600
-2,500
-25% -$67.3K
VIAV icon
111
Viavi Solutions
VIAV
$8.66B
$241K 0.05%
19,500
-25,500
-57% -$299K
ADMA icon
112
ADMA Biologics
ADMA
$2.04B
$233K 0.04%
61,300
+11,300
+23% +$39.9K
ENPH icon
113
Enphase Energy
ENPH
$4.79B
$230K 0.04%
+25,000
New +$190K
AZRE
114
DELISTED
Azure Power Global Limited
AZRE
$225K 0.04%
20,000
-7,500
-27% -$77.6K
ABEO icon
115
Abeona Therapeutics
ABEO
$343M
$221K 0.04%
1,200
+451
+60% +$80.6K
PLAN
116
DELISTED
Anaplan, Inc.
PLAN
$217K 0.04%
+5,500
New +$185K
VG
117
DELISTED
Vonage Holdings Corporation
VG
$201K 0.04%
+20,000
New +$192K
STKL
118
CALL
DELISTED
SunOpta
STKL
$200K 0.04%
57,800
-56,700
-50% -$219K
VOYA icon
119
Voya Financial
VOYA
$9.07B
$200K 0.04%
+4,000
New +$190K
APEN
120
DELISTED
Apollo Endosurgery, Inc.
APEN
$182K 0.03%
48,688
+311
+0.6% +$1.09K
GSM icon
121
CALL
FerroAtlántica
GSM
$628M
$164K 0.03%
+80,000
New +$182K
CGRN
122
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$135K 0.03%
15,000
+2,500
+20% +$21.5K
SEEL
123
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$134K 0.03%
10
+9
+900% +$146K
CSTM icon
124
Constellium
CSTM
$3.96B
$84K 0.02%
+10,500
New +$89.7K
NEPT
125
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$80K 0.02%
18
– –
3 4
5
6 7

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return

Ardsley Advisory Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Ardsley Advisory Partners held 160 positions worth $521M, up 31% from $398M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Ardsley Advisory Partners deployed $74M of net new capital in Q1 2019, opening 57 new positions and adding to 37 existing holdings. Its largest new stake was Medifast: 80,000 shares worth $10.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Sunrun, an estimated $11M trimmed.

  • Ardsley Advisory Partners's largest Q1 2019 buy was Medifast: 80,000 shares worth $10.2M.
  • Ardsley Advisory Partners added most to Celgene Corp in Q1 2019, an estimated $11.3M increase.
  • Ardsley Advisory Partners's biggest Q1 2019 reduction was Sunrun, cutting an estimated $11M.
  • Ardsley Advisory Partners fully exited Jazz Pharmaceuticals in Q1 2019, selling an estimated $13.6M.
  • Ardsley Advisory Partners's ten largest holdings make up 42% of its $521M portfolio in Q1 2019.
  • Ardsley Advisory Partners opened 57 new positions and closed 29 in Q1 2019.
  • Ardsley Advisory Partners's portfolio value rose 31% quarter-over-quarter to $521M.

Based on Ardsley Advisory Partners's 13F filing for Q1 2019, filed 15 May 2019.